For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Available treatments for COPD are mainly palliative ... destruction of the airways associated with the disease 7. Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and ...

Inhalers are crucial tools for people with lung conditions such as asthma or chronic obstructive pulmonary disease (COPD). Some people ... inhaler canister, tt's best to hold on to the packaging ...

GSK, leading the COPD market with its Trelegy ... therapies should not overshadow choosing the best therapy for each patient. "Are dry powder inhalers the key to sustainable respiratory care?" ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

The study involved 804 COPD patients exhibiting type 2 inflammation ... MATINEE achieved its primary endpoint, showing that adding mepolizumab to inhaled maintenance therapy significantly reduced ...